[zeusgodmd]

CEO and cfo buying shares is a good sign. Probably company will be sold tomorrow 

[zeusgodmd]

Boy this one has been quiet 

[Renee]

PTN changed to PTNT. Delisted from the AMEX to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions

[zeusgodmd]

Another drug coming just going to have to sit back and watch this 20 cent stock

[zeusgodmd]

Let's see which company wants to buy us.

[zeusgodmd]

Please let's see partner next week

[zeusgodmd]

Something is up after hours

[zeusgodmd]

Need to name a partner for this to fly

[zeusgodmd]

Should be 3$ today

[zeusgodmd]

They spent 3 billion dollars on a factory just to make more ozempic we have a drug showing better numbers.  Good weekend to kick back and make some deals with big pharmaceutical companies. Let's go spana 

[zeusgodmd]

Better than ozempic a billion dollar drug and 24 cents

[zeusgodmd]

Guess they have enough to run it

[zeusgodmd]

45 million total manipulation until they are forced to sell

[zeusgodmd]

30 million shares already more than float

[Meticulous1]

Any second of any day this week should bring this stock price back to $1.10 to 1.40Loading and hold...The big news is probably going to be the new partnership with the newly test diabetes type 2 drug.

[zeusgodmd]

Either bought enough to short more or they are buying up all the float today

[zeusgodmd]

Nice volume

[zeusgodmd]

Needs to make the deal with Lilly this weekend 

[zeusgodmd]

Where is the partnership he has been talking about

[zeusgodmd]

Looks like another good drug in to pipeline maybe team up with Jardiance

[zeusgodmd]

Lilly's drug working with this one and will be the one.

[zeusgodmd]

Crazy but I'll take it.

[zeusgodmd]

There are some idiots selling this today read the data. Lilly will be buying this company out

[zeusgodmd]

They are looking for a partner to help finance on going studies and partnership which is good so we don't dilute anymore

[gapole]

Had good news today and tk is down at .61

Palatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL8177

[zeusgodmd]

Over 6 million traded in one day and I can barely buy 15000 shares  every 1 hour is bullshit

[makinezmoney]

$PTN: Added 10k here at $0.82

On that dip from $1.14

Letsssssss goooooooooooooooooooooooooooo

GO $PTN

[zeusgodmd]

 Betting on tomorrow or Wednesday 

[zeusgodmd]

Ptn got new orphan drug approval. Will see what happens news coming

[zeusgodmd]

Sitting tight until next week

[zeusgodmd]

Results have to be this week.

[zeusgodmd]

Today or tomorrow maybe

[zeusgodmd]

Outcome data by the end of the month per ceo 

[zeusgodmd]

3 drugs coming out the end of there pipeline

[StocktonCA]

this Stock is on the move!!! finished Obesity drug study today, results will be released by end of this qquarter. price target $17. no brainer. flying under the radar......

[tw0122]

PTN .94 +9% ...19m float...

[StocktonCA]

HC Wainwright Reaffirms “Buy” Rating for Palatin Technologies (NYSEAMERICAN:PTN)



Posted by MarketBeat News on Jan 30th, 2025





Share on Twitter Share on Facebook Share on LinkedIn

Share on Stocktwits





?Palatin Technologies (NYSEAMERICAN:PTN – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research report issued to clients and investors on Tuesday,Benzinga reports. They currently have a $17.00 price objective on the biopharmaceutical company’s stock.

Palatin Technologies Trading Up 0.7 %

NYSEAMERICAN PTN opened at $0.91 on Tuesday. Palatin Technologies has a 1-year low of $0.68 and a 1-year high of $5.22. The stock has a market capitalization of $17.77 million, a PE ratio of -0.46 and a beta of 0.90.

Get Palatin Technologies alerts:

Institutional Trading of Palatin Technologies

Several large investors have recently added to or reduced their stakes in the stock. Virtu Financial LLC purchased a new position in shares of Palatin Technologies in the third quarter valued at $51,000. HB Wealth Management LLC lifted its holdings in Palatin Technologies by 86.3% in the 4th quarter. HB Wealth Management LLC now owns 110,500 shares of the biopharmaceutical company’s stock worth $127,000 after buying an additional 51,200 shares in the last quarter. Finally, XTX Topco Ltd acquired a new position in Palatin Technologies in the 2nd quarter worth $29,000. 11.50% of the stock is currently owned by institutional investors and hedge funds.

[zeusgodmd]

Nice level to buy some

[zeusgodmd]

Still nothing going on with ceo news

[zeusgodmd]

I don't think she is going to stop this time 

[zeusgodmd]

Need a company that's going to sell this product 

[zeusgodmd]

Nice results 

[zeusgodmd]

Hc wainwright 17$ price target was 75$ still a ways off of these 2 prices but 2 months will see

[zeusgodmd]

Can't buy big chipmunks of it

[zeusgodmd]

News any time

[zeusgodmd]

Meibo eye drops just came out for dry eyes saw commercial 

[zeusgodmd]

Far off from 17$ though

[zeusgodmd]

Looking good

[zeusgodmd]

Let hear about a partnership

[zeusgodmd]

Let’s go Merck or Pfizer